Intelligent Bio Solutions Receivables 2020-2025 | INBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions receivables from 2020 to 2025. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions receivables from 2020 to 2025. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$145.3B
CVS Health (CVS)	$75.4B
Elevance Health (ELV)	$64.4B
Cencora (COR)	$55.5B
DiDi Global (DIDIY)	$26B
Labcorp Holdings (LH)	$21.9B
Natera (NTRA)	$18.8B
BioMerieux (BMXMF)	$17.1B
ICON (ICLR)	$15.3B
EUROFINS SCIENT (ERFSF)	$14.9B
CochLear (CHEOY)	$13.4B
Solventum (SOLV)	$12.8B
Medpace Holdings (MEDP)	$12.7B
Revvity (RVTY)	$11.2B
Viatris (VTRS)	$10.9B
Avantor (AVTR)	$9.5B
Sonic Healthcare (SKHHY)	$9.2B
Charles River Laboratories (CRL)	$8.8B
HealthEquity (HQY)	$8.3B
Caris Life Sciences,�Inc (CAI)	$6.9B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$5.1B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.5B
Surgery Partners (SGRY)	$2.9B
Organon (OGN)	$2.6B
Concentras Parent (CON)	$2.6B
GeneDx Holdings (WGS)	$2.4B
Alignment Healthcare (ALHC)	$2.3B
Progyny (PGNY)	$2B